United Res Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for UNITED RES LABS
UNITED RES LABS has one approved drug.
Drugs and US Patents for United Res Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United Res Labs | COLESEVELAM HYDROCHLORIDE | colesevelam hydrochloride | TABLET;ORAL | 213456-001 | Jan 21, 2022 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

